S

SRTS

SRTS

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
20%Bearish
Buy/Sell Ratio100% buys
BearishBullish
SRTS Live QuoteReal-time
$2.36
$0.50(-17.48%)1M
Day Range$2.30 – $2.51
Open$2.30
Previous Close$2.30
Volume170.4K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$38.19M
P/E Ratio (TTM)24.5
Forward P/E21.4
EPS (TTM)$-0.97
Price to Book1.1
Dividend Yield0.65%
Beta (Volatility)1.27
IndustryMEDICAL DEVICES
52-Week RangeCurrent: $2.36 (7%)
Low: $2.14High: $5.49
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$5.25-96.5% upside

Insider Buys

3

$752K

Insider Sales

0

$0

Total Volume

$752K

15 transactions

Net Activity

+$752K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
85CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

2 Insiders

1 buys12 sells

$87.98B total

S
2

Sachetta Eric

Dir

1 buys0 sells

$183K total

C
3

Cornish Megan

Dir

1 buys0 sells

$5K total

Trading History
SRTS insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 17, 2026

2 days ago

Sachetta Eric

Dir

Director
Buy81.6K$2.24$183K

Nov 18, 2026

Yesterday

Cornish Megan

Dir

Director
Buy2.2K$2.28$5K

Aug 28, 2026

2 months ago

Multiple Insiders

2 Insiders

Insider
Buy171.2K$3.29$564K

Aug 28, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell296.9K$64841.00$19.25B

Aug 26, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell232.0K$20633.00$4.79B

Aug 24, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell211.4K$34697.00$7.34B

Aug 20, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.22M$20000.00$24.41B

May 12, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell145.7K$1500.00$218.56M

Feb 24, 2026

8 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell142.1K$2000.00$284.23M

Nov 21, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell140.1K$7000.00$980.79M

Nov 13, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell133.1K$2500.00$332.78M

Nov 18, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.20M$25000.00$30.01B

Nov 11, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell118.8K$2000.00$237.68M

Aug 13, 2025

15 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell116.8K$1000.00$116.84M

Feb 10, 2025

21 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell40.7K$501.00$20.41M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
SRTS Buy Conviction100%
Industry Rank#437 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

SRTS has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. SRTS ranks #437 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for SRTS

Over the last 90 days, corporate insiders at SRTS (SRTS) engaged in a total of 15 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 0 were sales. The total volume of insider trading reached $752K.

The net insider activity for SRTS shows a net buying bias of $752K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.20M shares valued at $30.01B on Nov 18, 2025.

Live Market News & Developments
Aggregated real-time headlines for SRTS (SRTS)
6 updates

Sensus Healthcare, Inc. (SRTS) stock price, news, quote and history

Yahoo Finance Singapore6d ago

Insider Spends US$72k Buying More Shares In Sensus Healthcare

Simply Wall St12h ago

Sensus Healthcare director Megan Cornish buys $5,016 in shares By Investing.com

Investing.com Canada3h ago

SRTS - Sensus Healthcare Inc Stock Price and Quote

Finviz177d ago

CDNL,ANGX,CC,BCDA,IDAI,AMRC,CUEN,LIEN,STRR,FISV,MSIF,RSG,SELF,CWBC,SPG,PSNY,FRST,TISI,REFI,MTDR,AFCG,AWRE,SRTS,BGDE | Stock Prices | Quote Comparison - Yahoo Finance

Yahoo! Finance Canada2h ago

Sensus Healthcare Director Megan Cornish Acquires 2,200 Shares at $2.28 Each

Kalkine Media55m ago

FAQs About SRTS Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for SRTS.

Based on SEC Form 4 disclosures, the Insider Confidence Score for SRTS is currently 85/100, which reflects a strong accumulation bias. This calculation accounts for a total of 3 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for SRTS is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.